Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19187341 | 0.71 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL50658 | 0.69 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL10153919 | 0.69 | DAO (0.38) | GABRA1GABRB2 | |
| SCHEMBL16806316 | 0.67 | DAO (0.37) | GABRA1GABRB2 | |
| SCHEMBL21720113 | 0.67 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL21737225 | 0.67 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL5057445 | 0.67 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL18540827 | 0.64 | DAO (0.35) | GABRA1GABRB2 | |
| SCHEMBL8130441 | 0.64 | KIF11 (0.33) | GABRA1GABRB2 | |
| SCHEMBL21720505 | 0.64 | GABRA1 (0.31) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255950-A1 | 3-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same | GEORGIA TECH RESEARCH CORPORATION | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255950-A1 | 3-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same | KDM1B, KDM3A, KDM1A | GABRA1 2559/4885GABRB2 2795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.